Steve Waisglass

Vivocore, Inc. is a non-invasive research and Canadian development company.

InterVivo Solutions, Inc. offers high-quality, translational drug discovery services to accelerate drug discovery programs to the clinic. The Canadian company provides a carefully selected array of neuroscience models and experiments to help propel new drugs forward through the development track. The private company's designed pharmacokinetics studies provide reliable data ensuring faster screening, selection, and development of lead candidates. The company has expertise in neurological disease models and laboratory testing capabilities to support emerging research. The company welcomes inquiries for novel approaches for model and bioanalytical development. Additionally, Transpharmation, a preclinical neuroscience CRO, relays a number of natural models of disease via the largest world-class canine colony in the industry. InterVivo Solutions can assist in discovering how they can help.

Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022.